‘Stretching the limits’: Pathology stocks soar amid record COVID tests
The company’s shares gained more than 12 per cent on Tuesday and a further 7.3 per cent on Wednesday morning, hitting a 12-month high of $6.11.
Loading
Meanwhile, shares in Sonic Health Care are up 4.6 per cent for the week and 37.9 per cent for the calendar year. The company will not provide revenue forecasts for 2022, citing the uncertainty of demand for testing, but said in a trading update last month it saw a 16 per cent increase in earnings in the four months of October, recording $991 million.
Healius shares are up by 2.8 per cent for the week and 42.2 per cent for the year so far. Back in August, chief executive Malcolm Parmenter confirmed the business will increase its investment in processing capabilities.
In a press conference on Wednesday, Victoria’s COVID-19 response commander, Jeroen Weimar said that the state’s testing sites could deal with an additional capacity of a few thousand tests before they were overwhelmed.
Mr Weimar said the state would like to see a reduction of the number of tests required for “bureaucratic reasons”.
Victoria hit a record of 92,262 tests performed on Tuesday.
The Market Recap newsletter is a wrap of the day’s trading. Get it each weekday afternoon.
For all the latest Business News Click Here
For the latest news and updates, follow us on Google News.